Gene therapy based on its SMaRT(tm) technology (spliceosome mediated RNA Trans-splicing gene therapy)

History:

Subsidiary of Proteome Sciences. Intronn was acquired by VIRxSYS in 2007.

Employment

Email:jobs@intronn.com

Fax:

Mail:
Dept. SC
Intronn Inc.
9700 Great Seneca Highway
Rockville MD 20850

General Info:

Ticker: subsidiary

Employees:

Regions:
Northeast

Research Focus:
Other

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: